Equities
Health CarePharmaceuticals and Biotechnology
  • Price (DKK)918.00
  • Today's Change23.00 / 2.57%
  • Shares traded208.69k
  • 1 Year change+202.57%
  • Beta0.9464
Data delayed at least 15 minutes, as of Sep 19 2024 16:10 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of DKK
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments1,6331,1781,428
Total Receivables, Net11183110
Total Inventory7.941.29118
Prepaid expenses356365
Other current assets, total(6.89)(8.7)--
Total current assets1,7801,3161,722
Property, plant & equipment, net150165221
Goodwill, net------
Intangibles, net12054
Long term investments213827
Note receivable - long term16181.27
Other long term assets----13
Total assets1,9801,5402,068
LIABILITIES
Accounts payable9218165
Accrued expenses85--85
Notes payable/short-term debt000
Current portion long-term debt/capital leases171515
Other current liabilities, total910170
Total current liabilities285195334
Total long term debt103509773
Total debt119524787
Deferred income tax------
Minority interest------
Other liabilities, total01933
Total liabilities3877241,140
SHAREHOLDERS EQUITY
Common stock595244
Additional paid-in capital6,406--4,250
Retained earnings (accumulated deficit)(4895)750(3308)
Treasury stock - common----(72)
Unrealized gain (loss)------
Other equity, total231514
Total equity1,593816928
Total liabilities & shareholders' equity1,9801,5402,068
Total common shares outstanding585143
Treasury shares - common primary issue0.370.230.42
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.